Defunct Company
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
90
NCT02500199
Phase I Study of Pyrotinib in Patients With HER2-positive Solid Tumors
Phase: Phase 1
Role: Lead Sponsor
Start: Jun 30, 2015
Completion: Jun 30, 2021
NCT03203811
A Phase 1, Study to Evaluate HTI-2088 Tablet
Start: Feb 17, 2017
Completion: Oct 23, 2017